Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress ...
This new clinical practice guideline provides a comprehensive process for assessing patients and residents for diabetes, ...
However, depression goes undiagnosed in 50%-75% of patients with chronic conditions such as diabetes mellitus. Additionally, there is limited information about the prevalence of depression among ...
The real-world retrospective study evaluated the impact of GIMOTI (metoclopramide nasal spray) in patients with diabetic gastroparesis (DGP) who were concurrently using GLP-1 receptor agonists.
Manx patients going into hospital have been reminded to make sure they take enough prescription medication with them for the duration of their stay. Manx Care said it was important for the team to ...
One of the most significant initiatives is focused on preventing blindness in people with diabetes through early ... AI-assisted screenings at no cost to patients over the next decade.
More than a thousand patients with advanced breast cancer are being denied a drug that can keep them alive for longer. It is already available in 19 countries in Europe - including in Scotland ...
A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...
For people with diabetes, controlling blood-sugar levels ... drugs to enable doctors to individualize therapies for their patients, he adds.
In the meantime, say doctors, lifestyle changes will remain the cornerstone of managing diabetes Different trials involving stem cell therapy are on in India, but studies are long-term and risks ...
RIO DE JANEIRO — Brazilian health officials are scrambling to explain how six transplant patients in the country’s well-regarded public health system received organs infected with HIV — and ...
Conclusions The intense simplified strategy using subsequent oral therapies post-SIIT, especially the linagliptin plus metformin combination, sustainably improved glycaemic control and β cell function ...